Patents by Inventor Alex Toker

Alex Toker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220226481
    Abstract: Disclosed are bifunctional compounds comprising a GDC-0068 analog that binds AKT isoforms AKT1, 2 and 3, pharmaceutical compositions, and methods for treating diseases or conditions mediated by dysfunctional AKT activity.
    Type: Application
    Filed: April 8, 2020
    Publication date: July 21, 2022
    Applicants: DANA-FARBER CANCER INSTITUTE, INC., BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
    Inventors: Nathanael Gray, Inchul You, Tinghu Zhang, Eric Fischer, Katherine Donovan, Emily Erickson, Alex Toker
  • Publication number: 20180117029
    Abstract: Methods for treating cancer in a subject by administering a therapeutically effective amount of a pyrimidine synthesis inhibitor and a genotoxic chemotherapeutic agent. In some embodiments, the cancer is triple negative breast cancer.
    Type: Application
    Filed: November 2, 2017
    Publication date: May 3, 2018
    Inventors: Alex Toker, Kristin K. Brown
  • Publication number: 20070100585
    Abstract: A method of device maintenance, comprising: providing a maintenance network including a user site and a multi-device servicing site that provides maintenance to at least one target device in said user site; selecting, by a user, a degree of access of maintenance functions of said servicing site to at least one of maintenance-related information of said target device and commanding said target device to perform a maintenance-related task; and setting said degree of access.
    Type: Application
    Filed: September 26, 2006
    Publication date: May 3, 2007
    Applicant: Nextnine Ltd.
    Inventors: Adi Dulberg, Gil Lenovai, Alex Toker
  • Publication number: 20050100897
    Abstract: The present invention provides therapeutic and diagnositic methods for neoplasia treatment. The invention also relates to determining the prognosis of a neoplasia or determining a treatment protocal. Further features of the invention are methods for identifying NFAT target genes that promote neoplasia progression.
    Type: Application
    Filed: March 31, 2003
    Publication date: May 12, 2005
    Inventors: Alex Toker, Sebastien Jauliac
  • Publication number: 20040025173
    Abstract: An abstraction unit, comprising a conversion module adapted to translate general instructions, having a format that is independent of a target device model, to specific instructions for each of a plurality of different target device models, said module having at least one programmable and user accessible rule element which defines said translation; and a presentation module adapted to receive responses from a plurality of said target devices, said module having at least one programmable and user accessible rule element which converts said responses into a standardized response format that is independent of the device model that sent the response.
    Type: Application
    Filed: April 24, 2003
    Publication date: February 5, 2004
    Inventors: Gil Levonai, Oren Minzer, Adi Dulberg, Alex Toker
  • Publication number: 20030023956
    Abstract: A generic software logging package (item 13 or FIG. 1) for using with a user software application (12). The software logging package includes at least one function which stores logging data into at least one logging buffer (17) and at least one macro command (20) which expands into a conditional call to the at least one function, the conditional call including a call statement which transfers to the called function at least one redundant parameter.
    Type: Application
    Filed: August 13, 2002
    Publication date: January 30, 2003
    Inventors: Adi Dulberg, Eldad Maniv, Alex Toker, Gil Levonai